Nationwide evaluation of mutation-tailored anti-EGFR therapy selection in patients with colorectal cancer in daily clinical practice

For a nationwide real-word data study on the application of predictive mutation testing of patients with colorectal cancer (CRC) for anti-epidermal growth factor receptor (EGFR) therapy stratification, pathology data were collected from the Dutch Pathology Registry from October 2017 until June 2019...

Descripción completa

Detalles Bibliográficos
Autores principales: Steeghs, Elisabeth M P, Vink, Geraldine R, Elferink, Marloes A G, Voorham, Quirinus J M, Gelderblom, Hans, Nagtegaal, Iris D, Grünberg, Katrien, Ligtenberg, Marjolijn J L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510427/
https://www.ncbi.nlm.nih.gov/pubmed/34675090
http://dx.doi.org/10.1136/jclinpath-2021-207865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510427/
https://www.ncbi.nlm.nih.gov/pubmed/34675090
http://dx.doi.org/10.1136/jclinpath-2021-207865

Ejemplares similares